Skip to main content
. Author manuscript; available in PMC: 2013 Jun 3.
Published in final edited form as: Shock. 2010 Feb;33(2):162–169. doi: 10.1097/SHK.0b013e3181aa9690

Fig. 4. Airway hyperresponsiveness and mediators of AHR in response to LPS tolerance.

Fig. 4

A, Airway hyperresponsiveness in response to increasing doses of aerosolized methacholine at 4 h post–final challenge. B, Bronchoalveolar lavage cysteinyl leukotriene concentrations at 2 h post–final challenge. C, Bronchoalveolar lavage tryptase concentrations at 2 h post–final challenge. Data are expressed as mean ± SEM (n = 6–10 mice per group). *P < 0.05 and **P < 0.01 compared with the nontolerant group.